Crispr Therapeutics AG (CRSP) CEO Rodger Novak Sells 49384 Shares of Stock – Chaffey Breeze
|
Crispr Therapeutics AG (CRSP) CEO Rodger Novak Sells 49384 Shares of Stock
Chaffey Breeze Crispr Therapeutics AG (NASDAQ:CRSP) CEO Rodger Novak sold 49,384 shares of the stock in a transaction dated Thursday, May 4th. The shares were sold at an average price of $16.30, for a total value of $804,959.20. Following the completion of the sale, … Crispr Therapeutics AG (CRSP) Insider Samarth Kulkarni Sells … Systemax Inc. (SYX) Reaches $17.15 52-Week High; Crispr Therapeutics AG (CRSP) Shorts Raised By 40.03% |
